Skip to main content

Deciphera Pharmaceuticals, Inc.

DCPHDelisted Jun 11, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001654151

Deciphera Pharmaceuticals, Inc. was delisted on Jun 11, 2024; its insiders filed their last Form 4 on Jun 11, 2024; 177 institutions reported holding it in 13F filings for Q1 2024, worth $943.7M in total; no superinvestor held it.

Q1 2023 vs. Q4 2022

How the institutions holding Deciphera Pharmaceuticals, Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of DCPH: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders143147+4
Shares52.3M58.0M+5.76M (+11.0%)
Value$856.4M$896.5M+$40.1M (+4.7%)

New holders (26)

Institutions that held Deciphera Pharmaceuticals, Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to DCPH in Q1 2023
InstitutionSharesValue% of portfolio
Deep Track Capital, LP1,363,201$21.1M0.90%
Woodline Partners LP339,905$5.25M0.07%
Norges Bank287,068$4.44M0.00%
Bank of Montreal169,194$2.62M0.00%
Point72 Asset Management, L.P.73,951$1.14M0.00%
AlphaCentric Advisors LLC72,500$1.12M0.77%
UBS Oconnor LLC58,695$906.8K0.02%
Wells Fargo & Company48,390$747.6K0.00%
Profund Advisors LLC43,547$672.8K0.04%
AQR Capital Management LLC31,350$484.4K0.00%
New York Life Investment Management LLC30,577$472.4K0.01%
Fox Run Management, L.L.C.25,248$390.1K0.13%
Bayesian Capital Management, LP22,411$346.3K0.04%
Alyeska Investment Group, L.P.20,400$315.2K0.00%
Los Angeles Capital Management LLC18,118$279.9K0.00%
Connor, Clark & Lunn Investment Management Ltd.15,887$245.5K0.00%
Belvedere Trading LLC13,866$214.2K0.09%
Massachusetts Financial Services Co13,530$209.0K0.00%
Envestnet Asset Management Inc12,629$195.1K0.00%
Janus Henderson Group PLC11,504$177.7K0.00%
Man Group plc–$154.7K0.00%
Lazard Asset Management LLC8,421$130.0K0.00%
Dark Forest Capital Management LP891$13.8K0.00%
Simplex Trading, LLC645$9.00K0.00%
TCI Wealth Advisors, Inc.290$4.48K0.00%
Global Retirement Partners, LLC100$1.39K0.00%

Sold out (22)

Institutions that held Deciphera Pharmaceuticals, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.